United States · FDA National Drug Code directory

Digoxin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-3156_11443c80-fca0-4c9e-be13-a5f92717a715
Product NDC
71335-3156
Form
TABLET
Composition / generic term
Digoxin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20220901
Source listing expiry
20271231

Source-listed ingredients

  • DIGOXIN — 250 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-3156-1) · 71335-3156-1
  • 60 TABLET in 1 BOTTLE (71335-3156-2) · 71335-3156-2
  • 90 TABLET in 1 BOTTLE (71335-3156-3) · 71335-3156-3
  • 100 TABLET in 1 BOTTLE (71335-3156-4) · 71335-3156-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →